Generated by DeepSeek V3.2| Bragg peak | |
|---|---|
| Name | Bragg peak |
| Field | Medical physics, Particle therapy |
| Related | Proton therapy, Hadron therapy, Linear energy transfer |
Bragg peak. In particle physics and medical physics, the Bragg peak refers to the sharp peak in the energy loss of a charged particle, such as a proton or carbon ion, as it travels through matter. This phenomenon, characterized by a low dose in the entry path and a concentrated, high dose at a specific depth, is fundamental to advanced forms of radiation oncology. Its unique dose distribution is exploited in treatments like proton therapy to precisely target malignant tumors while sparing surrounding healthy tissue.
The physical basis for this effect is described by the Bethe formula, which quantifies the rate of energy loss for charged particles via ionization and excitation of atoms in a medium like water or human tissue. As a particle like a proton from a cyclotron or synchrotron slows down, its cross section for interaction increases, leading to a dramatic rise in linear energy transfer near the end of its range. The precise depth of the peak is determined by the particle's initial kinetic energy, which is controlled by the treatment device. The sharp fall-off beyond the peak occurs because the particle rapidly loses its remaining energy and comes to rest, a principle first observed by William Henry Bragg and his son William Lawrence Bragg.
In clinical practice, this principle is harnessed in facilities like the Massachusetts General Hospital and the University of Pennsylvania to treat cancers in sensitive areas such as the brain, spinal cord, and pediatric cases. By modulating the beam energy, clinicians can create a spread-out Bragg peak that conforms the high-dose region to the three-dimensional shape of a tumor volume. This technique, central to particle therapy, allows for superior dose conformity compared to conventional photon beams from a linear accelerator, significantly reducing integral dose to the patient. The ability to spare critical structures like the optic nerve or brainstem is a major advantage documented in trials by institutions like the Mayo Clinic.
Accurate prediction and verification of the peak's position and shape are critical for treatment planning and quality assurance. Measurement is typically performed using devices such as a water phantom equipped with an ionization chamber or a diode detector. Advanced treatment planning systems, like those from Varian Medical Systems or IBA Dosimetry, use Monte Carlo method simulations to calculate dose deposition, accounting for tissue heterogeneities such as bone or lung. These calculations are benchmarked against data from organizations like the International Atomic Energy Agency to ensure safety and accuracy in clinical protocols.
The depth-dose profile stands in stark contrast to that of megavoltage X-ray beams from a Cobalt-60 unit or linear accelerator, which exhibit a maximum dose at a shallow depth followed by a gradual exponential decrease. Similarly, electron beam therapy provides a more superficial dose distribution without a pronounced peak. The sharp distal fall-off of the peak offers a distinct advantage over intensity-modulated radiation therapy for tumors adjacent to radiosensitive organs, as demonstrated in studies at the MD Anderson Cancer Center. However, techniques like stereotactic radiosurgery with Gamma Knife can achieve high conformity for small intracranial lesions using photons.
The effect is named for physicist William Henry Bragg, who, with his son William Lawrence Bragg, conducted pioneering work on the penetration of alpha particles through matter in the early 20th century, research honored by the Nobel Prize in Physics. The potential for cancer treatment was first proposed by Robert R. Wilson in a seminal paper published after his work on the Manhattan Project. Clinical application began in the 1950s at research facilities like the Lawrence Berkeley National Laboratory using particle accelerators originally built for nuclear physics. Widespread adoption in radiation therapy accelerated in the 1990s with technological advances from companies like Hitachi and the establishment of dedicated centers such as the Loma Linda University Medical Center.
Category:Medical physics Category:Radiation therapy Category:Particle physics